BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 8184813)

  • 1. Loop diuretic discontinuation in chronic heart failure patients: A retrospective study.
    Silva G; Moura B; Moreira E; Dias CC; Pinto BS; Campelo M; Amorim S; Martins E; Pinto R; Araújo PM; Resende CX; Mena B; Grácio T; Silva Cardoso J
    Rev Port Cardiol; 2024 Jun; ():. PubMed ID: 38906521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diuretics in pregnancy: Data from the ESC Registry of Pregnancy and Cardiac disease (ROPAC).
    van der Zande JA; Greutmann M; Tobler D; Ramlakhan KP; Cornette JMJ; Ladouceur M; Collins N; Adamson D; Paruchuri VP; Hall R; Johnson MR; Roos-Hesselink JW;
    Eur J Heart Fail; 2024 Jun; ():. PubMed ID: 38837327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Changing Role of Loop Diuretics in Heart Failure Management across the Last Century.
    Palazzuoli A; Mazzeo P; Fortunato M; Cadeddu Dessalvi C; Mariano E; Salzano A; Severino P; Fedele F
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review.
    van Poelgeest EP; Handoko ML; Muller M; van der Velde N;
    Eur Geriatr Med; 2023 Aug; 14(4):659-674. PubMed ID: 36732414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic Therapy in Heart Failure - Current Approaches.
    Casu G; Merella P
    Eur Cardiol; 2015 Jul; 10(1):42-47. PubMed ID: 30310422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluid Management in Patients with Chronic Heart Failure.
    Pellicori P; Kaur K; Clark AL
    Card Fail Rev; 2015 Oct; 1(2):90-95. PubMed ID: 28785439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of short-term omission of daily medication on the pathophysiology of heart failure.
    Dovancescu S; Pellicori P; Mabote T; Torabi A; Clark AL; Cleland JGF
    Eur J Heart Fail; 2017 May; 19(5):643-649. PubMed ID: 28295907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure: chapter 8. Treatment of end-stage heart failure.
    de Jonge N; Vantrimpont PJ
    Neth Heart J; 2004 Dec; 12(12):548-554. PubMed ID: 25696289
    [No Abstract]   [Full Text] [Related]  

  • 9. Congestion is the driving force behind heart failure.
    Guglin M
    Curr Heart Fail Rep; 2012 Sep; 9(3):219-27. PubMed ID: 22699923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretics as pathogenetic treatment for heart failure.
    Guglin M
    Int J Gen Med; 2011 Jan; 4():91-8. PubMed ID: 21403798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furosemide responsiveness, non-adherence and resistance during the chronic treatment of heart failure: a longitudinal study.
    MacFadyen RJ; Gorski JC; Brater DC; Struthers AD
    Br J Clin Pharmacol; 2004 May; 57(5):622-31. PubMed ID: 15089816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction.
    van Kraaij DJ; Jansen RW; Gribnau FW; Hoefnagels WH
    Drugs Aging; 2000 Apr; 16(4):289-300. PubMed ID: 10874524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical case studies in heart failure management.
    MacFadyen RJ; Shiels P; Struthers AD
    Br J Clin Pharmacol; 1999 Mar; 47(3):239-47. PubMed ID: 10215746
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of captopril and ibopamine in mild to moderate heart failure.
    Dohmen HJ; Dunselman PH; Poole-Wilson PA
    Heart; 1997 Sep; 78(3):285-90. PubMed ID: 9391292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy.
    Grinstead WC; Francis MJ; Marks GF; Tawa CB; Zoghbi WA; Young JB
    Am J Cardiol; 1994 May; 73(12):881-6. PubMed ID: 8184813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial.
    Rohde LE; Rover MM; Figueiredo Neto JA; Danzmann LC; Bertoldi EG; Simões MV; Silvestre OM; Ribeiro ALP; Moura LZ; Beck-da-Silva L; Prado D; Sant'Anna RT; Bridi LH; Zimerman A; Raupp da Rosa P; Biolo A
    Eur Heart J; 2019 Nov; 40(44):3605-3612. PubMed ID: 31424503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and Design of the "Safety and Efficacy of the Combination of Loop with Thiazide-type Diuretics in Patients with Decompensated Heart Failure (CLOROTIC) Trial:" A Double-Blind, Randomized, Placebo-Controlled Study to Determine the Effect of Combined Diuretic Therapy (Loop Diuretics With Thiazide-Type Diuretics) Among Patients With Decompensated Heart Failure.
    Trullàs JC; Morales-Rull JL; Casado J; Freitas Ramírez A; Manzano L; Formiga F;
    J Card Fail; 2016 Jul; 22(7):529-36. PubMed ID: 26576715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.